Atom | Breakthrough T1D Request for Applications: Development of Continuous C-Peptide Monitoring Technologies

Due Dates: December 4, 2025 (Letter of Intent) | February 12, 2026 (Full proposal)

Funding Amounts: Up to $900,000 total over 3 years; larger budgets considered with strong justification.

Summary: Supports development and validation of innovative continuous C-peptide monitoring technologies for real-time assessment of beta cell function in type 1 diabetes.

Key Information: LOI approval is required before submitting a full proposal; both academic and industry applicants are eligible.

Breakthrough T1D Request for Applications: Development of Continuous C-Peptide Monitoring Technologies

Sign in to see full grant listing